Nebivolol ( DrugBank: Nebivolol )

4 diseases

17. 多系統萎縮症

臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01044693 (ClinicalTrials.gov)	January 2010	6/1/2010	Nebivolol in the Supine Hypertension of Autonomic Failure	Effect of Nebivololon Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric ...	Hypertension;Pure Autonomic Failure;Multiple System Atrophy	Drug: Placebo;Drug: Nebivolol 5 mg;Drug: metoprolol tartrate 50 mg;Drug: Sildenafil25 mg	Vanderbilt University	Forest Laboratories	Completed	18 Years	80 Years	All	20	N/A	United States

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04888728 (ClinicalTrials.gov)	June 30, 2021	28/4/2021	To Evaluate Drug-drug Interactions Between DWN12088 and Nebivololor Paroxetine in Healthy Volunteers ...	An Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12 ...	Idiopathic Pulmonary Fibrosis	Drug: DWN12088;Drug: Nebivolol;Drug: Paroxetine	Daewoong Pharmaceutical Co. LTD.	NULL	Completed	20 Years	55 Years	Male	24	Phase 1	Korea, Republic of

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01648634 (ClinicalTrials.gov)	February 13, 2012	20/7/2012	Nebivololfor the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscu ...	A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Examine the Effect of Nebivolo ...	Duchenne Muscular Dystrophy;Cardiomyopathy;Heart Failure	Drug: Nebivolol;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	Association Française contre les Myopathies (AFM), Paris	Completed	10 Years	15 Years	Male	51	Phase 3	France
2	EUCTR2010-020047-12-FR (EUCTR)		01/04/2011	Effet d’un traitement préventif par Nebivolol chez les enfants atteints de dystrophie de Duchenne	Etude de l'effet d'un traitement préventif par Nebivololsur l'apparition et la progression de la dys ...	Enfants atteints de dystrophie de Duchenne MedDRA version: 13.1;Level: PT;Classification code 100138 ...	Trade Name: Temerit Product Name: Temerit INN or Proposed INN: Nébivolol	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: no Male: yes	70	Phase 3	France

臨床試験数 : 21 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 50

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001462-81-IT (EUCTR)	27/10/2008	17/03/2008	Effects of Losartan versus Nebivololversus the association of both on the progression of aortic root ...	Effects of Losartan versus Nebivololversus the association of both on the progression of aortic root ...	Marfan Syndrome MedDRA version: 9.1;Level: LLT;Classification code 10026829;Term: Marfan's syndrome	Trade Name: LORTAAN28CPR RIV DIV 50MG INN or Proposed INN: Losartan Trade Name: LOBIVON28CPR 5MG INN ...	OSPEDALE POLICLINICO S. MATTEO	NULL	Not Recruiting			Female: yes Male: yes		Phase 3	Italy
2	NCT00683124 (ClinicalTrials.gov)	July 2008	21/5/2008	NebivololVersus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan ...	Effects of Losartan vs. Nebivololvs. the Association of Both on the Progression of Aortic Root Dilat ...	Marfan Syndrome	Drug: Losartan and nebivolol;Drug: Losartan;Drug: Nebivolol	IRCCS Policlinico S. Matteo	Merck Sharp & Dohme Corp.;Menarini Group	Recruiting	12 Months	55 Years	Both	291	Phase 3	Italy